Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
619.00    -7.00 (-1.12%)
Bid:
617.00
Ask:
619.00
Spread: 2.00 (0.324%)
Market Cap: £1.14b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Trading Update

15 Oct 2020 07:00

RNS Number : 1183C
Volex PLC
15 October 2020
 

15 October 2020

 

Volex plc

("Volex" or the "Company")

 

Trading Update

 

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is today issuing a trading update ahead of the scheduled announcement of the group's interim results for the 26 weeks ended 4 October 2020, on 12 November 2020. 

COVID-19

 

We are continuing to monitor the global situation in respect of COVID-19. The health, safety and well-being of our colleagues remain our principal responsibility and we are providing our facilities with our full support, following all public health advice, and complying with all government directives. All manufacturing facilities remained fully operational following adaptations that were made in the first quarter in response to the COVID-19 pandemic.

 

Trading

 

Volex's performance has continued to improve since the group last updated the market at our Annual General Meeting on 30 July 2020.

 

Consequently, the board now expects revenue and profitability to be above current market expectations for both the half-year period and the full year as a whole.

 

· Unaudited revenue for the six months ended 4 October 2020 is expected to be at least $200 million, which represents an increase of 2.2 per cent over the same period a year earlier;

 

· Underlying operating profit is expected to be at least $20 million, which represents an increase of 25.8 per cent over the same period a year earlier;

 

· Net cash excluding lease liabilities as at 2 October 2020 was approximately $31 million.

 

Executive Chairman Nat Rothschild commented:

 

"We enter the final quarter of calendar 2020 in a healthy position. Our geographic and customer diversification continues to provide the business with a high degree of visibility at this time while ongoing demand for consumer electronics remains strong and the global shift to electric vehicles gathers pace.

 

Absent another widespread COVID-19 related global lockdown, given the robust performance in the first half of the year, coupled with our strong forward order book position, the board expects to see a strong performance for the year as a whole that will be above current market expectations.

 

I would like to extend my sincere thanks to the entire Volex team for their invaluable contribution to this strong performance as we look ahead to the second half of the year with cautious optimism." 

 

For further information please contact:

 

Volex plc

+44 (0)7909 995 887

Nat Rothschild, Executive Chairman

 

Daren Morris, Chief Financial Officer

 

 

Powerscourt - Media Enquiries

+44 (0)20 7250 1446

James White

 

Jack Holden

 

 

N+1 Singer - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

 

Iqra Amin

 

 

Panmure Gordon - Joint Broker

+44 (0)20 7886 2500

Hugh Rich

 

Nick Lovering

 

 

 

NOTES TO EDITORS:

Volex plc (AIM:VLX) is a leading integrated manufacturing specialist. The Group designs and manufactures products that ensure a critical connection never fails and are used in everything from defibrillators and ventilators through to data networking equipment and vehicle telematics. Headquartered in the United Kingdom, Volex serves the needs of its blue-chip customer base from its manufacturing sites located across nine countries and three continents, employing over 6,000 people. Volex's products are sold through its own global sales force and through distributors to Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing Services companies. For more information please visit www.volex.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFEFILESSEIS
Date   Source Headline
1st Jul 20147:00 amRNSResult of Placing and Open Offer
27th Jun 20144:05 pmRNSDirector/PDMR Shareholding
25th Jun 20144:04 pmRNSAnnual Report & Accounts & Notice of AGM
20th Jun 20147:00 amRNSDirector/PDMR Shareholding
18th Jun 20147:00 amRNSDirector/PDMR Shareholding
17th Jun 20147:00 amRNSDirector/PDMR Shareholding
12th Jun 20147:01 amRNSProposed Placing and Open Offer
12th Jun 20147:00 amRNSPreliminary results for year ended 30 March 2014
8th May 201411:22 amRNSHolding(s) in Company
7th May 20147:00 amRNSTelecoms Order Intake Update
30th Apr 20147:00 amRNSTrading Statement
9th Apr 20147:00 amRNSTrading Statement
13th Mar 20147:00 amRNSDirector/PDMR Shareholding
12th Feb 20147:00 amRNSInterim Management Statement
20th Jan 20149:53 amRNSDirector/PDMR Shareholding - REPLACEMENT
17th Jan 20142:36 pmRNSDirector/PDMR Shareholding
16th Jan 20147:00 amRNSDirectorate Change
13th Jan 20149:39 amRNSTotal Voting Rights
7th Jan 201411:12 amRNSAppointment of Senior Independent Director
13th Dec 20138:35 amRNSCompletion of Placing & Secondary Share Sale
13th Dec 20137:00 amRNSPlacing
21st Nov 20132:47 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
14th Nov 20137:00 amRNSDirectorate Change
14th Nov 20137:00 amRNSDirectorate Changes
14th Nov 20137:00 amRNSHalf Yearly Report
12th Nov 20132:46 pmRNSTotal Voting Rights
25th Oct 20131:49 pmRNSDirector/PDMR Shareholding
24th Oct 201312:09 pmRNSDirectorate Change
16th Oct 201311:52 amRNSScrip Dividend Circular
16th Oct 20137:00 amRNSDirectorate Change
14th Oct 20135:13 pmRNSScrip Dividend Issue of Shares
23rd Sep 20134:53 pmRNSDirector/PDMR Shareholding
11th Sep 20131:58 pmRNSScrip Calculation Price for October 2013
2nd Sep 20133:05 pmRNSTotal Voting Rights - REPLACEMENT
2nd Sep 20132:03 pmRNSTotal Voting Rights
20th Aug 20133:10 pmRNSNew Ordinary Shares issued
14th Aug 20135:55 pmRNSDirector/PDMR Shareholding
14th Aug 201311:15 amRNSAdditional Listing
12th Aug 201312:00 pmRNSDirector/PDMR Shareholding
8th Aug 20137:00 amRNSBoard change
22nd Jul 20135:01 pmRNSVoting Results of 2013 Annual General Meeting
22nd Jul 20137:00 amRNSDirectorate Change
22nd Jul 20137:00 amRNSInterim Management Statement
24th Jun 201310:05 amRNSAnnual Financial Report
7th Jun 201311:17 amRNSDirector/PDMR Shareholding
30th May 20139:15 amRNSDirector/PDMR Shareholding
28th May 20138:01 amRNSAppointment of new Chief Executive
28th May 20137:00 amRNSPreliminary results for year ended 31 March 2013
17th May 20137:00 amRNSHolding(s) in Company
8th May 20134:52 pmRNSVolex launches new Active Optical Cable Products

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.